PembrolizumabSubacute parkinsonism: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2042卷 / 1期

关键词：

D O I：

10.1007/s40278-025-75209-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：410 / 410

相关论文

共 50 条

[1] PembrolizumabSubacute polyarticular inflammatory arthritis: case report
Reactions Weekly, 2016, 1629 (1) : 201 - 201
[2] PembrolizumabSubacute cutaneous lupus erythematosus: case report
Reactions Weekly, 2025, 2044 (1) : 301 - 301
[3] PembrolizumabSubacute cutaneous lupus erythematosus: case report
Reactions Weekly, 2021, 1845 (1) : 319 - 319
[4] PembrolizumabSubacute polyarticular inflammatory arthritis: case report
Reactions Weekly, 2017, 1659 (1) : 242 - 242
[5] PembrolizumabSubacute inflammatory demyelinating polyradiculoneuropathy: case report
Reactions Weekly, 2019, 1755 (1) : 264 - 264
[6] Ipilimumab/nivolumab/pembrolizumabSubacute cutaneous lupus erythematosus: case report
Reactions Weekly, 2020, 1801 (1) : 153 - 153
[7] MefloquineFirst report of parkinsonism: case report
Reactions Weekly, 2007, 1159 (1) : 20 - 20
[8] TacrolimusFirst report of parkinsonism: case report
Reactions Weekly, 2011, 1343 (1) : 29 - 29
[9] AdalimumabFirst report of parkinsonism: case report
Reactions Weekly, 2005, 1048 (1) : 6 - 6
[10] KavainFirst report of parkinsonism: case report
Reactions Weekly, 2002, 895 (1) : 8 - 8

← 1 2 3 4 5 →